Steve Holloway[email protected]Clinical NewsWas the NHS to blame in U.K. cyberattack?The WannaCry ransomware cyberattack left parts of the U.K. National Health Service (NHS) at a standstill. Operations were canceled, MRI and CT units had to be shut down, and staff reverted to paper notes. Columnist Stephen Holloway asks what lessons we can learn from this attack.May 22, 2017Market AnalysisThe great enabler: Artificial intelligence in radiologyMuch has already been debated over the effect of artificial intelligence (AI) for radiology, and now the first products have started to enter the market. AI will not replace radiologists, but enable them, according to market analyst Stephen Holloway.March 23, 2017Market AnalysisWalking a gadolinium tightrope of perception & bottom lineThe recommendation by the European Medicines Agency on 10 March that market authorization for four linear gadolinium contrast agents be suspended shocked the radiology community, but what will be the business repercussions? Analyst Stephen Holloway gives his assessment.March 21, 2017Market AnalysisWhere next for digital x-ray?Digital flat-panel detector radiography is dominant in Europe, but with a vast array of apparently similar systems on offer, it's hard to predict where the market is heading. Analyst Stephen Holloway identifies the key themes in digital x-ray.March 15, 2017Market AnalysisGap widens between CT innovation and installationOf all the major imaging modalities on show in the exhibition halls at ECR 2017, it's arguable that none have undergone such transformation over the last decade as CT. Following safety concerns and the increasing use of MRI and ultrasound, CT has had to reinvent itself, market analyst Stephen Holloway writes.March 12, 2017ConferenceA step closer to Doc McCoy's beloved toy?The idea of handheld ultrasound is not a new one, with first-generation systems being available for almost a decade. These first devices were a marvel in shrinking ultrasound technology into a smartphone-sized device. But what about now? Market analyst Stephen Holloway addresses updates on the modality.March 9, 2017ConferenceDoes breast MRI hold future for mammography market?Clinical evidence supporting the use of MRI for breast imaging is growing in volume and credibility. Further research is required, but evidence suggests MRI has a significant future role to play. So why have we seen little or no commercial impact from breast MRI? Market analyst Stephen Holloway reports.March 7, 2017Clinical NewsHard Brexit signals rocky road for radiologyThe U.K. looks set to leave the European Union single market and opt for a so-called hard Brexit. In his new column, Stephen Holloway discusses the implications for medical imaging and healthcare IT, focusing on the U.K. National Health Service, regulatory aspects, and the market impact.January 24, 2017Clinical NewsBack to the future: Top themes from RSNA 2016What does the vast exhibition at the RSNA 2016 meeting tell us about where radiology is heading? Recently back from Chicago, market expert Stephen Holloway does some crystal-ball gazing and explains why interoperability is the major challenge ahead.December 18, 2016Industry NewsAdvanced visualization: Why so many viewers?It's safe to expect artificial intelligence and big data will be front and center of RSNA 2016. Perhaps less expected will be the abundance of visualization software on display, Stephen Holloway writes in his latest column.November 20, 2016Previous PagePage 3 of 5Next PageTop StoriesMRILow sexual desire manifests as dimorphic brain processing on fMRIMen and women with hypoactive sexual desire disorder (HSDD) show dimorphic brain processing on functional MRI, researchers from a top London facility have reported.Emergency RadiologyJAMA: Radiology among least affected services in Ukraine warEnterprise ImagingAgfa secures agreement with Dublin hospitalCTUse CCTA to track vasculopathy risk in heart transplant patientsSponsor ContentJourney to the Cloud: A Snapshot of Market Progress - 22 May @ 7pm CET